Geopolitical tensions with the US and the allure of cheaper and quicker trials are drawing Chinese biotechs developing ...
On July 4, the Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch was held in Beijing. Jointly organized by Liaowang Finance, under Liaowang Weekly, and ...
Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...
Naming challenges, combination trials and AI augmentation are forcing pharma brands to establish strategic differentiation ...
The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization, today announced a strategic partnership with BlueRock Therapeutics, a leader in stem cell therapeutic ...
In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes ...
Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
NTxscribe FLEX is a flexible, purpose-built system that gives researchers and development teams direct control over their RNA production process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results